Key result
Chemogenetic inhibition of the glutamatergic paraventricular nucleus to tyrosine hydroxylase-expressing rostral ventrolateral medulla circuit reduced myocardial ischemia/reperfusion injury in mice.
Why the study?
Whether myocardial ischemia/reperfusion injury is centrally mediated and its underlying processing hierarchy remained elusive.
Does inhibition of the PVN-RVLM neural circuit or sympathetic blockade reduce myocardial ischemia/reperfusion injury in a mouse model?
Does inhibition of the PVN-RVLM neural circuit or sympathetic blockade reduce myocardial ischemia/reperfusion injury in a mouse model?
Answers are grounded in this paper and cite their sources.
Identification of a brain-heart neural circuit (PVN to RVLM) that mediates myocardial ischemia/reperfusion injury provides a novel potential therapeutic target for cardiovascular disease.
Myocardial ischemia/reperfusion injury (MIRI), the major pathophysiology of cardiovascular disease, is a crucial therapeutic focus. To date, whether MIRI is centrally mediated and its underlying processing hierarchy remain elusive. We show that the electrical activity of the paraventricular nucleus (PVN) and rostral ventrolateral medulla (RVLM) neurons increased after MIRI in a mouse model. We identified a neural circuit involving glutamatergic projections from the paraventricular nucleus (Glu PVN ) to tyrosine hydroxylase–expressing neurons in the rostral ventrolateral medulla (TH RVLM ) that contributes to MIRI. Transneuronal tracing with neurotropic viruses indicated that the TH RVLM neurons project directly to the spinal preganglionic neurons and then to the stellate ganglion, two critical neural nodes along the brain–heart axis. Chemogenetic inhibition of the Glu PVN →TH RVLM circuit or cervical sympathetic blockade reduced the level of norepinephrine in the heart and thereby prevented MIRI. Furthermore, pharmacological blockade of myocardium β-receptors also reduced MIRI. This brain–heart circuit that promotes MIRI represents a potential therapeutic target for MIRI treatment.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2023) studied Myocardial ischemia/reperfusion injury (MIRI). Chemogenetic inhibition of the GluPVN→ THRVLM circuit or cervical sympathetic blockade vs. Sham or control virus was evaluated on Myocardial infarct size relative to area at risk (IS/AAR) and serum cTnI concentration. Chemogenetic inhibition of the glutamatergic paraventricular nucleus to tyrosine hydroxylase-expressing rostral ventrolateral medulla circuit reduced myocardial ischemia/reperfusion injury in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: